[
  {
    "ts": null,
    "headline": "Health Care Slides After Lilly Warning - Health Care Roundup",
    "summary": "Health Care Slides After Lilly Warning - Health Care Roundup",
    "url": "https://finnhub.io/api/news?id=ccfac144068e0a9f5aa1d76f39dbbffcfa774130a4b8d4f1ecb928a90aa4b7dc",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736874960,
      "headline": "Health Care Slides After Lilly Warning - Health Care Roundup",
      "id": 132407704,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "Health Care Slides After Lilly Warning - Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=ccfac144068e0a9f5aa1d76f39dbbffcfa774130a4b8d4f1ecb928a90aa4b7dc"
    }
  },
  {
    "ts": null,
    "headline": "PBMs Generated Billions in Drug Markups, FTC Says",
    "summary": "PBMs Generated Billions in Drug Markups, FTC Says",
    "url": "https://finnhub.io/api/news?id=34ee4220e4c1b2656d6051acb85b83df541857dfb2032cee3d3998a480b83e06",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736868840,
      "headline": "PBMs Generated Billions in Drug Markups, FTC Says",
      "id": 132407800,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "PBMs Generated Billions in Drug Markups, FTC Says",
      "url": "https://finnhub.io/api/news?id=34ee4220e4c1b2656d6051acb85b83df541857dfb2032cee3d3998a480b83e06"
    }
  },
  {
    "ts": null,
    "headline": "Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says",
    "summary": "Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says",
    "url": "https://finnhub.io/api/news?id=f7ed329194ae85c77c5033528408d69f61321770242f1b35b0f5445db2f26c92",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736868360,
      "headline": "Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says",
      "id": 132407771,
      "image": "",
      "related": "CVS",
      "source": "DowJones",
      "summary": "Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says",
      "url": "https://finnhub.io/api/news?id=f7ed329194ae85c77c5033528408d69f61321770242f1b35b0f5445db2f26c92"
    }
  },
  {
    "ts": null,
    "headline": "FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%",
    "summary": "FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%",
    "url": "https://finnhub.io/api/news?id=a2911fed071b307cccece0c8a4174a9219b8a4d66cecf49d9e72f38d1f77fb26",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736865960,
      "headline": "FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%",
      "id": 132407801,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%",
      "url": "https://finnhub.io/api/news?id=a2911fed071b307cccece0c8a4174a9219b8a4d66cecf49d9e72f38d1f77fb26"
    }
  },
  {
    "ts": null,
    "headline": "Patient Capital Management Q4 2024 Investment Review",
    "summary": "During the fourth quarter of 2024, the Patient Opportunity Equity Strategy generated a total return of 8.2% net of fees. Read more here.",
    "url": "https://finnhub.io/api/news?id=4c46c494af86e68782518c362fabf40854d5bfb319dcb8fb785b81e230f6b6f1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736829600,
      "headline": "Patient Capital Management Q4 2024 Investment Review",
      "id": 132392476,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1089222846/image_1089222846.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "During the fourth quarter of 2024, the Patient Opportunity Equity Strategy generated a total return of 8.2% net of fees. Read more here.",
      "url": "https://finnhub.io/api/news?id=4c46c494af86e68782518c362fabf40854d5bfb319dcb8fb785b81e230f6b6f1"
    }
  },
  {
    "ts": null,
    "headline": "Mawer Investment Management Q4 2024 Quarterly Update",
    "summary": "Global central banks continued to ease this quarter, though the pace of easing varied. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=eb3c9d01a0e3e4d0e687644b5609193c2889554d59153afbc8e9cbe3a4a3e999",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736827500,
      "headline": "Mawer Investment Management Q4 2024 Quarterly Update",
      "id": 132392313,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2163730037/image_2163730037.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Global central banks continued to ease this quarter, though the pace of easing varied. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=eb3c9d01a0e3e4d0e687644b5609193c2889554d59153afbc8e9cbe3a4a3e999"
    }
  },
  {
    "ts": null,
    "headline": "Patient Capital Management Q4 2024 Commentary",
    "summary": "Patient Capital Management's Opportunity Equity Strategy surpassed the market to end up 26.5%, 150bps ahead of the S&P 500âs 25.0%. Click here to read the full fund letter.",
    "url": "https://finnhub.io/api/news?id=c91a9f164536b2ce0ecd620d1784405dbcd0ebf51731ed1a3244af49ec114ad7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736826000,
      "headline": "Patient Capital Management Q4 2024 Commentary",
      "id": 132392179,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Patient Capital Management's Opportunity Equity Strategy surpassed the market to end up 26.5%, 150bps ahead of the S&P 500âs 25.0%. Click here to read the full fund letter.",
      "url": "https://finnhub.io/api/news?id=c91a9f164536b2ce0ecd620d1784405dbcd0ebf51731ed1a3244af49ec114ad7"
    }
  }
]